title: Cardiac magnetic resonance imaging in pulmonary arterial hypertension.
abstract: Cardiac magnetic resonance imaging (CMRI) provides accurate information about right ventricular (RV) mass, RV volumes and other markers of RV function. CMRI is proving to be a particularly useful tool in pulmonary arterial hypertension (PAH), as measures of RV function have been shown to be prognostic of long-term outcomes in this disease. Changes in RV function can also provide important information about a patient's disease course and response to treatment. As CMRI is noninvasive it can be used to regularly monitor patients with PAH, which is an important advantage over invasive right heart catheterisation. This review will explore the use of CMRI in the context of existing monitoring tools for PAH and will explore the forthcoming developments that are likely to be important in the future monitoring of patients with PAH.
authors.affiliation: Scottish Pulmonary Vascular Unit, Glasgow, UK. 2 Dept of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Peacock
authors.forename: Anton
authors.initials: A
authors.lastname: Vonk Noordegraaf
mesh_terms: D018450:Disease Progression; D065627:Familial Primary Pulmonary Hypertension; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D008279:Magnetic Resonance Imaging; D011237:Predictive Value of Tests; D016896:Treatment Outcome; D018497:Ventricular Dysfunction, Right / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D016278:Ventricular Function, Right